NCT01523639 / 2011-001010-34: A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis |
|
|
| Terminated | 2 | 8 | Europe | Metformin/Placebo, Glucophage | Austrian Breast & Colorectal Cancer Study Group, Merck Gesellschaft mbH, Austria | Colorectal Cancer, Steatohepatitis | 11/13 | 04/14 | | |
